Scholar Rock Holding (SRRK) Asset Utilization Ratio (2019 - 2022)
Scholar Rock Holding (SRRK) recorded quarterly Asset Utilization Ratio of 0.09 in Q4 2022, down 3.02% quarter-over-quarter from 0.09 in Q3 2022, and up 42.08% on a YoY basis from 0.06 in Q4 2021.
Scholar Rock Holding (SRRK) Asset Utilization Ratio (2019 - 2022) Analysis & Trends
Scholar Rock Holding's Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.09 for Q4 2022.
- In Q4 2022, Asset Utilization Ratio rose 42.08% year-over-year to 0.09; the TTM figure through Dec 2022 stood at 0.09 (up 42.08% YoY), while the FY2022 annual figure was 0.1, up 84.43% from the prior year.
- Asset Utilization Ratio was 0.09 for Q4 2022 at Scholar Rock Holding, down from 0.09 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.17 in Q1 2022 to a low of 0.04 in Q1 2021.
- Historically, Asset Utilization Ratio has averaged 0.09 across 4 years, with a median of 0.09 in 2022.
- The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio tumbled 66.57% in 2021, then jumped 311.78% in 2022.
- A 4-year view of Asset Utilization Ratio shows it stood at 0.11 in 2019, then plunged by 47.56% to 0.06 in 2020, then increased by 11.8% to 0.06 in 2021, then soared by 42.08% to 0.09 in 2022.
- The last three Asset Utilization Ratio figures came in at 0.09 (Q4 2022), 0.09 (Q3 2022), and 0.12 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | 0.12 |
| Mar 31, 2022 | 0.17 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.05 |
| Mar 31, 2021 | 0.04 |
| Dec 31, 2020 | 0.06 |
| Sep 30, 2020 | 0.12 |
| Jun 30, 2020 | 0.13 |
| Mar 31, 2020 | 0.12 |
| Dec 31, 2019 | 0.11 |
| Sep 30, 2019 | 0.07 |
| Jun 30, 2019 | 0.04 |